ESTRO37_ProgrammeBook

14:30 > Lessons Learned from RTOG 0617 Speaker: J. Bradley (USA)

SP-0109

SATURDAY 21 APRIL 2018

14:51 > Combining systemic therapy with hypofractionation in locally dvanced NSCLC: Best of both worlds, or double-trouble? G. Hanna (United Kingdom), A. Greystoke, S. Brown, A. Chalmers, D. Sebag-Montefiore 15:12 > Model-based approach to select the optimal technology for LA-NSCLC Speaker: J. Sonke (The Netherlands) 15:33 > Dose to cardiac substructures predicts survival in non-small cell lung cancer chemo-radiotherapy M. Thor (USA), A. Hotca, A. Jackson, E. Yorke, A. Rimner, J. Deasy

SP-0110

SP-0111

OC-0112

SYMPOSIUM Blood borne biomarkers 14:30 - 15:45  | ROOM 120-121

Chair: C. Vens (The Netherlands) Co-Chair: J.L. Lopez Guerra (Spain)

14:30 > Circulating tumour DNA as a therapeutic biomarker for radiotherapy Speaker: S. Bratman (Canada)

SP-0113

14:55 > Circulating tumour cell (CTC) analysis in radiotherapy patients Speaker: A. Hudson (United Kingdom)

SP-0114

15:20 > Predicting radiation toxicity: what is the link between mitochondrial DNA and individual radio sensitivity? Speaker: C. Oberije (The Netherlands), M.W. Van Gisbergen, E. Smeets, B. Smeets, P. Lambin

SP-0115

JOINT SYMPOSIUM ESTRO-ASTRO: The art and science of head and neck radiotherapy 14:30 - 15:45  | ROOM AUDITORIUM

Chair: Y. Lievens (Belgium) Chair: B. Kavanagh (USA)

14:30 > The status of reduced RT dose therapy for HPV+ cancer Speaker: S. Nuyts (Belgium)

SP-0116

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

86